Olink®Part of Thermo Fisher Scientific
Capture true biological insights with proven specificity. At any scale.
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 1,800 and growing rapidly – covering all major disease areas
Help shape the future of health research with Olink’s cutting-edge technology
Filters
Journal of Nutrition, 2021Proposed Anti-Inflammatory Diet Reduces Inflammation in Compliant, Weight-Stable Patients with Rheumatoid Arthritis in a Randomized Controlled Crossover Trial
Hulander, E., Bärebring et al.
Olink Target 96
Nature Communications, 2021High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer
Rogic A., Pant I., Grumolato L. et al.
Nature Communications, 2021Synergistic insights into human health from aptamer- and antibody-based proteomic profiling
Pietzner M., Wheeler E., Carrasco-Zanini J. et al.
Circulation, 2021Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease
Katz D., Tahir U., Bick A. et al.
Olink Explore 3072/384
The Lancet Regional Health - Europe, 2021Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources
Davidson L., van den Reek J., Bruno M. et al.
Translational Research, 2021Novel associations between inflammation-related proteins and adiposity: A targeted proteomics approach across four population-based studies
Ponce-de-Leon M., Linseisen J., Peters A. et al.
Science, 2021Mapping the proteo-genomic convergence of human diseases
Nature Communications, 2021Elevated circulating follistatin associates with an increased risk of type 2 diabetes
Wu C., Borné Y., Gao R. et al.
Diabetology & Metabolic Syndrome, 2021Proteins associated with incident metabolic syndrome in population-based cohorts
Lind L., Sundström J., Ärnlöv J.
Scientific Reports, 2021A dry immersion model of microgravity modulates platelet phenotype, miRNA signature, and circulating plasma protein biomarker profile
Twomey L., Navasiolava N., Robin A. et al.
Pathogens, 2021In Vitro 3D Staphylococcus aureus Abscess Communities Induce Bone Marrow Cells to Expand into Myeloid-Derived Suppressor Cells
Hofstee M., Heider A., Häckel S. et al.
Olink Target 96 Mouse
Diabetologia, 2021The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease: evidence from cross-sectional, longitudinal and Mendelian randomisation analyses
Drake I., Fryk E., Strindberg L. et al.
Translational Psychiatry, 2021Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia
Costi S., Morris L., Collins A. et al.
ESC Heart Failure, 2021Impact of natriuretic peptide polymorphisms on diastolic and metabolic function in a populational cohort: insights from the STANISLAS cohort
Xhaard C., Rouget R., Vodovar N. et al.
Xhaard, C., Rouget et al.
Scientific Reports, 2021Biomarkers of subclinical atherosclerosis in patients with psoriasis
Kaiser H., Wang X., Kvist-Hansen A. et al.
Biochemical and Biophysical Research Communications, 2021Ultra-sensitive techniques for detecting neurological biomarkers: Prospects for early diagnosis
Kumar D., Hassan M.
Kaiser, H., Wang et al.
American Journal of Respiratory Cell and Molecular Biology, 2021Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19
Russell C., Valanciute A., Gachanja N. et al.
Journal of Thrombosis and Thrombolysis, 2021Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes
Shavadia J., Alemayehu W., deFilippi C. et al.
1945 publications
Items per page
1181-1200 of 1945 publications